PHACTR2-AS1

gene
On this page

Also known as NR027113lncIHS

Summary

PHACTR2-AS1 (PHACTR2 antisense RNA 1, HGNC:40943) is a long non-coding RNA gene on chromosome 6q24.2.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:40943
Approved symbolPHACTR2-AS1
NamePHACTR2 antisense RNA 1
Location6q24.2
Locus typeRNA, long non-coding
StatusApproved
AliasesNR027113, lncIHS
Ensembl geneENSG00000235740
Ensembl biotypelncRNA
Entrez285740
RNAcentralURS000075E59A — lncRNA, 2134 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 lncRNA

ENST00000450575, ENST00000657644, ENST00000661155

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000450575 — 5 exons

ExonStartEnd
ENSE00001613570143561167143561468
ENSE00001675814143561885143562031
ENSE00001689174143554325143555230
ENSE00001722798143557999143558131
ENSE00001786426143557531143557741

Expression profiles

Bgee: expression breadth broad, 74 present calls, max score 97.69.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0271 / max 22.1032, expressed in 3 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
760440.01813
760430.00903

Top tissues by expression

171 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001997.69gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047390.12gold quality
left testisUBERON:000453384.56gold quality
right testisUBERON:000453483.67gold quality
testisUBERON:000047382.00gold quality
colonic epitheliumUBERON:000039771.99gold quality
bone marrow cellCL:000209266.64silver quality
epithelium of nasopharynxUBERON:000195159.18gold quality
adult organismUBERON:000702358.28gold quality
uterine cervixUBERON:000000258.20silver quality
mucosa of paranasal sinusUBERON:000503057.90gold quality
hindlimb stylopod muscleUBERON:000425257.18silver quality
ganglionic eminenceUBERON:000402356.07gold quality
monocyteCL:000057655.90gold quality
superficial temporal arteryUBERON:000161455.73gold quality
cardia of stomachUBERON:000116254.41gold quality
inferior vagus X ganglionUBERON:000536354.33gold quality
superior vestibular nucleusUBERON:000722754.17gold quality
ventral tegmental areaUBERON:000269153.92gold quality
mammary ductUBERON:000176553.89gold quality
saphenous veinUBERON:000731853.85gold quality
trigeminal ganglionUBERON:000167553.83gold quality
subthalamic nucleusUBERON:000190653.83gold quality
layer of synovial tissueUBERON:000761653.81gold quality
dorsal plus ventral thalamusUBERON:000189753.80gold quality
pericardiumUBERON:000240753.73gold quality
dorsal root ganglionUBERON:000004453.57gold quality
thymusUBERON:000237053.48gold quality
nippleUBERON:000203053.41gold quality
renal medullaUBERON:000036253.38gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.66

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 4)

  • lncRNA NR027113 can promote the proliferation, invasion and metastasis of hepatocellular carcinoma via the PTEN/PI3K/AKT signaling pathway. (PMID:30468465)
  • LncRNA NR027113 promotes malignant progression of gastric carcinoma via EMT signaling pathway. (PMID:31210301)
  • The EZH2-PHACTR2-AS1-Ribosome Axis induces Genomic Instability and Promotes Growth and Metastasis in Breast Cancer. (PMID:32312833)
  • Long non-coding RNA PHACTR2-AS1 promotes tongue squamous cell carcinoma metastasis by regulating Snail. (PMID:32702100)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.